Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer

被引：0
|
作者：
Zaisheng Ye
Yi Zeng
Shenghong Wei
Yi Wang
Zhitao Lin
Shu Chen
Zhiwei Wang
Shanshan Chen
Luchuan Chen
机构：
[1] Fujian Cancer Hospital & Fujian Medical University Cancer Hospital,Department of Gastrointestinal Surgical Oncology
[2] Fujian Cancer Hospital & Fujian Medical University Cancer Hospital,Department of Fujian Provincial Key Laboratory of Tumor Biotherapy
来源：
BMC Cancer | / 21卷
关键词：
Unresectable gastric cancer; Conversion therapy; Apatinib; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Conversion therapy for unresectable intrahepatic cholangiocarcinoma using gemcitabine plus S-1 combined with PD-1 inhibitors: a case report
    Zhao, Shuangying
    Zhang, Xiaodong
    Luo, Jialiang
    Yan, Huanjun
    Zhang, Jianlei
    Lin, Rongfeng
    Zhu, Kelei
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [32] Preliminary report on the short-term efficacy and safety of SAPO-S1 therapy for locally advanced gastric cancer with a deep learning perspective
    Lin, Yecheng
    Zhang, Lei
    Zhang, Xiaoling
    Wei, Xiaonan
    Liu, Xu
    Xie, Yanchao
    Han, Guoda
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (03) : 2704 - 2719
  • [33] Oral maintenance therapy using apatinib combined with S-1/capecitabine for esophageal squamous cell carcinoma with residual disease after definitive chemoradiotherapy
    Chi, Dongmei
    Chen, Baoqing
    Guo, Suping
    Bai, Kunhao
    Ma, Huali
    Hu, Yonghong
    Li, Qiaoqiao
    Zhu, Yujia
    AGING-US, 2021, 13 (06): : 8408 - 8420
  • [34] Inetetamab combined with S-1 and oxaliplatin as first-line treatment for human epidermal growth factor receptor 2-positive gastric cancer
    Kong, Ying
    Dong, Qi
    Jin, Peng
    Li, Ming-Yan
    Ma, Li
    Yi, Qi-Jun
    Miao, Yu-E
    Liu, Hai-Yan
    Liu, Jian-Gang
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (40) : 4367 - 4375
  • [35] Efficacy of Conversion Surgery Following Apatinib Plus Paclitaxel/S1 for Advanced Gastric Cancer With Unresectable Factors: A Multicenter, Single-Arm, Phase II Trial
    Xu, Zhiyuan
    Hu, Can
    Yu, Jianfa
    Du, Yian
    Hu, Ping
    Yu, Guofa
    Hu, Conggang
    Zhang, Yu
    Mao, Wei
    Chen, Shanqi
    Cheng, Xiangdong
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [36] Long-term Results of Conversion Therapy for Initially Unresectable Gastric Cancer: Analysis of 122 Patients at the National Cancer Center in China
    Wang, Tongbo
    Wang, Nianchang
    Ren, Hu
    Zhou, Hong
    Zhou, Aiping
    Jin, Jing
    Chen, Yingtai
    Zhao, Dongbing
    JOURNAL OF CANCER, 2019, 10 (24): : 5975 - 5985
  • [37] Short-term efficacy and influencing factors of conventional chemotherapy combined with irinotecan in patients with advanced gastric cancer
    Wang, Jun-Ping
    Du, Tian-Lei
    Li, Ya-Ying
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (01) : 143 - 154
  • [38] Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
    Shi, Min
    Yang, Zhongyin
    Lu, Sheng
    Liu, Wentao
    Ni, Zhentian
    Yao, Xuexin
    Hua, Zichen
    Feng, Runhua
    Zheng, Yanan
    Wang, Zhenqiang
    Sah, Birendra Kumar
    Chen, Mingmin
    Zhu, Zhenglun
    He, Changyu
    Li, Chen
    Zhang, Jun
    Yan, Chao
    Yan, Min
    Zhu, Zhenggang
    BMC CANCER, 2021, 21 (01)
  • [39] The long-term survival of stage IV gastric cancer patients with conversion therapy
    Yamaguchi, Kazuya
    Yoshida, Kazuhiro
    Tanahashi, Toshiyuki
    Takahashi, Takao
    Matsuhashi, Nobuhisa
    Tanaka, Yoshihiro
    Tanabe, Kazuaki
    Ohdan, Hideki
    GASTRIC CANCER, 2018, 21 (02) : 315 - 323
  • [40] The long-term survival of stage IV gastric cancer patients with conversion therapy
    Kazuya Yamaguchi
    Kazuhiro Yoshida
    Toshiyuki Tanahashi
    Takao Takahashi
    Nobuhisa Matsuhashi
    Yoshihiro Tanaka
    Kazuaki Tanabe
    Hideki Ohdan
    Gastric Cancer, 2018, 21 : 315 - 323
12345